Evista Shortage Update: What Patients Need to Know in 2026

If you've searched for "Evista shortage" or "raloxifene out of stock" recently, you're not alone. Patients who rely on Evista (raloxifene) for osteoporosis management and breast cancer risk reduction frequently encounter availability challenges at their local pharmacies. Here's the latest on Evista's availability status and what you can do if your pharmacy can't fill your prescription.

Current Evista Shortage Status (2026)

As of 2026, Evista (raloxifene) is NOT listed on the FDA's official drug shortage database. The FDA maintains this database to track medications with a meaningful nationwide supply disruption — and raloxifene is not currently on it.

However, this does not mean every pharmacy in the country has Evista in stock. Local and regional availability varies. Some pharmacies — particularly smaller independents, rural locations, or those that don't routinely stock women's bone health medications — may not carry it regularly or may run out between shipments.

Why Does It Feel Like a Shortage If There Isn't One?

The gap between "no national shortage" and "my pharmacy doesn't have it" is one of the most frustrating aspects of prescription drug availability in the U.S. Here are some reasons you may be experiencing difficulty:

Demand-based ordering. Some pharmacies only order Evista or generic raloxifene when a patient requests it. If previous patients switched pharmacies or stopped filling there, the pharmacy may have stopped stocking it.

Brand vs. generic split. Your pharmacy may stock generic raloxifene but not brand-name Evista, or vice versa. The drug is available, just in the other form.

Manufacturer transitions. Multiple generic companies produce raloxifene. If one manufacturer temporarily pauses production, some wholesalers may have gaps while sourcing from another manufacturer.

Specialty drug status at some pharmacies. Although raloxifene is not a specialty drug by formal definition, some pharmacies categorize it as a low-demand specialty item and order it infrequently.

Historical Availability of Evista

Evista (raloxifene) has a relatively strong supply history compared to higher-profile shortage drugs. It was FDA-approved in 1997 and has had generic competition since the mid-2010s. Multiple manufacturers — including Aurobindo Pharma and others — produce generic raloxifene, which diversifies supply and reduces risk of a prolonged shortage.

That said, any drug dependent on international supply chains for active pharmaceutical ingredients can experience temporary disruptions. Raloxifene has not been free from all supply pressures, but it has not experienced the widespread, sustained shortages seen with drugs like amoxicillin, Adderall, or certain GLP-1 receptor agonists.

What Should You Do If Your Pharmacy Is Out of Evista?

If your pharmacy tells you they're out of stock, take these steps:

Ask when they expect their next shipment. Most pharmacies receive orders from wholesalers within 1–3 business days of placing an order.

Ask about brand vs. generic. If they're out of one form, they may have the other. Check with your prescriber about substitution.

Use medfinder. medfinder calls pharmacies near you to check which can fill your prescription, and texts you the results — saving hours of phone tag.

Try a different pharmacy. Large chain pharmacies (CVS, Walgreens, Walmart, Costco) are more likely to stock raloxifene regularly. Transfer your prescription if needed.

Set up mail-order pharmacy. Mail-order pharmacies ship 90-day supplies and rarely run out of common generics like raloxifene. This is the best long-term fix for supply disruption.

Should You Be Concerned About Missing Doses?

For osteoporosis treatment, missing a few days of Evista is unlikely to cause significant harm, as bone health changes slowly over months and years. For breast cancer risk reduction, consistency matters over the long term — but a short gap while you locate your medication is not typically considered clinically significant. Always contact your prescriber if you expect to miss more than a week of doses.

Bottom Line for 2026

There is no widespread national Evista shortage as of 2026. Local gaps exist, but generic raloxifene is manufactured by multiple companies and is broadly available through the wholesale distribution system. If your pharmacy can't fill your script, try another location — or use medfinder to find the closest pharmacy with stock. If access problems persist, talk to your doctor about Evista alternatives that may be easier for you to access.